Hologic Inc. logo

Hologic Inc. (HOLX)

Market Closed
5 Dec, 20:00
NASDAQ (NGS) NASDAQ (NGS)
$
74. 97
+0.11
+0.15%
$
16.67B Market Cap
38.79 P/E Ratio
0% Div Yield
1,652,346 Volume
3.91 Eps
$ 74.86
Previous Close
Day Range
74.83 75.09
Year Range
51.9 80.31
Want to track HOLX and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Earnings results expected in 59 days
With HOLX Stock Near 52-Week High, Should You Buy More or Play Safe?

With HOLX Stock Near 52-Week High, Should You Buy More or Play Safe?

Hologic's business diversification holds strong potential internationally. Also, its discounted valuation makes it attractive from an investment perspective.

Zacks | 1 year ago
Investors Heavily Search Hologic, Inc. (HOLX): Here is What You Need to Know

Investors Heavily Search Hologic, Inc. (HOLX): Here is What You Need to Know

Hologic (HOLX) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.

Zacks | 1 year ago
Why Hologic (HOLX) is a Top Value Stock for the Long-Term

Why Hologic (HOLX) is a Top Value Stock for the Long-Term

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

Zacks | 1 year ago
Why Is Hologic (HOLX) Down 3.4% Since Last Earnings Report?

Why Is Hologic (HOLX) Down 3.4% Since Last Earnings Report?

Hologic (HOLX) reported earnings 30 days ago. What's next for the stock?

Zacks | 1 year ago
Here is What to Know Beyond Why Hologic, Inc. (HOLX) is a Trending Stock

Here is What to Know Beyond Why Hologic, Inc. (HOLX) is a Trending Stock

Hologic (HOLX) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.

Zacks | 1 year ago
Should You Hold Hologic (HOLX) Stock in Your Portfolio Now?

Should You Hold Hologic (HOLX) Stock in Your Portfolio Now?

Hologic's (HOLX) strength in molecular diagnostics and the enriched Breast Health business are encouraging.

Zacks | 1 year ago
Is Trending Stock Hologic, Inc. (HOLX) a Buy Now?

Is Trending Stock Hologic, Inc. (HOLX) a Buy Now?

Hologic (HOLX) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.

Zacks | 1 year ago
Hologic (HOLX) Q3 Results Review: How to Play the Stock Now?

Hologic (HOLX) Q3 Results Review: How to Play the Stock Now?

Hologic's (HOLX) performance in the third quarter of fiscal 2024 marks a return to growth, along with revenues and earnings beating estimates. Read on to find out what else the stock holds.

Zacks | 1 year ago
Hologic (HOLX) International Revenue in Focus: Trends and Expectations

Hologic (HOLX) International Revenue in Focus: Trends and Expectations

Examine the evolution of Hologic's (HOLX) overseas revenue trends and their effects on Wall Street's forecasts and the stock's prospects.

Zacks | 1 year ago
Hologic, Inc. (HOLX) is Attracting Investor Attention: Here is What You Should Know

Hologic, Inc. (HOLX) is Attracting Investor Attention: Here is What You Should Know

Zacks.com users have recently been watching Hologic (HOLX) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.

Zacks | 1 year ago
Brokers Suggest Investing in Hologic (HOLX): Read This Before Placing a Bet

Brokers Suggest Investing in Hologic (HOLX): Read This Before Placing a Bet

Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision about a stock. While media reports about rating changes by these brokerage-firm employed (or sell-side) analysts often affect a stock's price, do they really matter?

Zacks | 1 year ago
Hologic (HOLX) Q3 Earnings Surpass Estimates, Margins Rise

Hologic (HOLX) Q3 Earnings Surpass Estimates, Margins Rise

Hologic (HOLX) delivers strong performances across all its franchises in the third quarter of fiscal 2024.

Zacks | 1 year ago
Loading...
Load More